Coherus BioSciences (CHRS) Reports Q3 Loss Per Share of $1.86
Get Alerts CHRS Hot Sheet
Price: $2.02 -7.34%
Financial Fact:
Depreciation and amortization: 14.21M
Today's EPS Names:
NLY, CP, RUSHA, More
Financial Fact:
Depreciation and amortization: 14.21M
Today's EPS Names:
NLY, CP, RUSHA, More
Join SI Premium – FREE
Coherus BioSciences (NASDAQ: CHRS) reported Q3 EPS of ($1.86), versus ($1.79) reported last year. Revenue for the quarter came in at $7.2 million, versus $16.1 million reported last year.
For earnings history and earnings-related data on Coherus BioSciences (CHRS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ATN International (ATNI) Misses Q1 EPS by 46c ; Offers Guidance
- Core Laboratories (CLB) Misses Q1 EPS by 13c
- O'Reilly Automotive (ORLY) Misses Q1 EPS by 7c, Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!